Cover Image

Emerging Effects of Sevelamer in Chronic Kidney Disease

Sevelamer, a non-absorbable anion exchange resin, is used to control hyperphosphatemia in chronic kidney disease (CKD) by binding to dietary phosphate in the gastrointestinal tract. Lipid-lowering effect is a widely recognized pleiotropic effect of sevelamer. In addition, many studies have reported...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ryota Ikee (Author), Masataka Tsunoda (Author), Naomi Sasaki (Author), Naritsugu Sato (Author), Nobuo Hashimoto (Author)
Format:	Book
Published:	Karger Publishers, 2013-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical Factors Associated With Serum Copper Concentration In Patients On Hemodialysis
by: Ryota Ikee, et al.
Published: (2012)

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
by: Vincenzo Savica, et al.
Published: (2008)

Practical use of sevelamer in chronic kidney disease patients on dialysis in People’s Republic of China
by: Meng L, et al.
Published: (2015)

Different Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Calcium Balance in Patients with Moderate to Advanced Chronic Kidney Disease
by: Makowka A, et al.
Published: (2021)

Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease
by: Darius L. Mason, et al.
Published: (2022)

Effect of sevelamer on serum phosphorus levels in chronic kidney disease and hemodialysis patients; a systematic review and meta-analysis
by: Farshad Gharebakhshi, et al.
Published: (2024)

Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease-A Comparative Clinical Study
by: Parminder Nain, et al.
Published: (2023)

The effects of sevelamer carbonate on blood glucose and inflammatory factors in patients with diabetic kidney disease; a controlled clinical trial
by: Shadi Botshekan, et al.
Published: (2021)

Efficacy and Safety of Sevelamer Carbonate in Chinese Nondialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized, Double-Blind, Parallel-Group Study
by: Wei Chen, et al.
Published: (2022)

Binding interactions with sevelamer and polystyrene sulfonate in vitro
by: Inge R.F. vanBerlo‐van de Laar, et al.
Published: (2021)

Sevelamer hydrochloride and coronary artery calcification in chronic hemodialysis patients: a new mechanism of action
by: Bahaa Eldin Zayed, et al.
Published: (2015)

Sevelamer arsenite nanoparticle as a Pi-responsive drug carrier and embolic agent for chemoembolization
by: Qiu-Chen Bi, et al.
Published: (2022)

Multi-Modal Treatment Of Calciphylaxis With Sodium-Thiosulfate, Cinacalcet And Sevelamer Including Long-Term Data
by: Hermann Salmhofer, et al.
Published: (2013)

The Therapeutic Effects of Sevelamer on Blood Sugar, HbA1c, Lipid Profile, and hs-CRP in Patients with Diabetic Nephropathy
by: Sosan Mohammadi Kebar, et al.
Published: (2018)

Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease
by: Hunter W. Korsmo, et al.
Published: (2024)

Chronic kidney disease: The emerging challenge and the way forward
by: Geetha Mani, et al.
Published: (2015)

Current and Emerging Drugs in the Treatment of Anemia in Patients with Chronic Kidney Disease
by: Hongzhen Zhong, et al.
Published: (2020)

Acetic acid treatment causes renal inflammation and chronic kidney disease in mice
by: Terumasa Hashimoto, et al.
Published: (2021)

Acute kidney injury and rehabilitation outcomes among elderly patients with chronic kidney disease
by: Naomi Nacasch, et al.
Published: (2023)

Advances in the Prevention and Treatment of Inflammation-Associated Preterm Birth
by: Nobuo Masataka
Published: (2016)

Near-infrared spectroscopy (NIRS) in functional research of prefrontal cortex
by: Nobuo Masataka
Published: (2016)

Ameliorative effects of pirfenidone in chronic kidney disease
by: Samad Ghodrati, et al.
Published: (2022)

The effect of allopurinol on the progression of chronic kidney disease
by: Aygul Ozdemir, et al.
Published: (2017)

Chronic Kidney Disease
Published: (2012)

Acute Kidney Injury and Chronic Kidney Disease
by: N. Kevin Krane
Published: (2012)

Emerging immunotherapies for autoimmune kidney disease
by: Mary Helen Foster, et al.
Published: (2019)

Niacin in patients with chronic kidney disease: Is it effective and safe?
by: Cheol Whee Park
Published: (2013)

Chronic Kidney Disease and Urological Implications: The interplay between Chronic Kidney Disease and urological conditions
by: Shashi Kumar, et al.
Published: (2024)

Aging and Chronic Kidney Disease
by: Kosaku Nitta, et al.
Published: (2014)

Anemia in chronic kidney disease
by: Prit Pal Singh, et al.
Published: (2023)

Malnutrition in Chronic Kidney Disease
by: Franca M. Iorember
Published: (2018)

Diuretics in chronic kidney disease
by: A. I. Dyadyk, et al.
Published: (2020)

Pregnancy in Chronic Kidney Disease
by: Larisa Shehaj, et al.
Published: (2023)

Novel Insights on Chronic Kidney Disease, Acute Kidney Injury and Polycystic Kidney Disease
Published: (2012)

Chronic Metabolic Acidosis in Chronic Kidney Disease
by: Daniel Patschan, et al.
Published: (2020)

The gut-kidney connection in advanced chronic kidney disease
by: Reiko Inagi
Published: (2015)

Collection of biochemical samples with brain-wide electrophysiological recordings from a freely moving rodent
by: Daichi Konno, et al.
Published: (2019)

Polypharmacy and the Progression of Chronic Kidney Disease: Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease
by: Hyang Ki Min, et al.
Published: (2021)

Chronic Kidney Disease from Pathophysiology to Clinical Improvements
Published: (2018)

Relationship of plasma 3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropanoic acid concentration with OATP1B activity in patients with chronic kidney disease
by: Hiroyuki Ono, et al.
Published: (2024)